Stockscreener 앱 받기
0.9786
1.04%
0.0114
전일 마감가:
$0.9672
열려 있는:
$1.04
하루 거래량:
2.77M
Relative Volume:
2.76
시가총액:
$81.47M
수익:
$24.99M
순이익/손실:
$-118.64M
주가수익비율:
-0.747
EPS:
-1.31
순현금흐름:
$-100.25M
1주 성능:
-2.27%
1개월 성능:
+20.62%
6개월 성능:
+81.99%
1년 성능:
-29.69%
1일 변동 폭
$0.9175
$1.0899
1주일 범위
$0.7896
$1.0899
52주 변동 폭
$0.4471
$1.54
Adicet Bio Inc Stock (ACET) Company Profile
명칭
Adicet Bio Inc
전화
617-482-2333
주소
131 DARTMOUTH STREET, BOSTON
ACET을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ACET
Adicet Bio Inc
|
0.9786 | 148.23M | 24.99M | -118.64M | -100.25M | -1.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.60 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.79 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.54 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
801.70 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.41 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Adicet Bio Inc Stock (ACET) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-09-30 | 재개 | Guggenheim | Buy |
| 2024-09-11 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2023-06-27 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-06-27 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2023-06-01 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-09-21 | 개시 | JP Morgan | Overweight |
| 2022-03-31 | 개시 | SMBC Nikko | Outperform |
| 2022-03-08 | 개시 | Truist | Buy |
| 2022-03-04 | 개시 | Jefferies | Buy |
| 2021-05-18 | 개시 | BTIG Research | Buy |
| 2021-04-23 | 개시 | H.C. Wainwright | Buy |
| 2021-04-14 | 개시 | Canaccord Genuity | Buy |
| 2021-04-08 | 개시 | Guggenheim | Buy |
| 2020-11-04 | 개시 | B. Riley Securities | Buy |
| 2020-10-27 | 개시 | JMP Securities | Mkt Outperform |
| 2020-10-16 | 개시 | Wedbush | Outperform |
모두보기
Adicet Bio Inc 주식(ACET)의 최신 뉴스
How sentiment analysis helps forecast Adicet Bio Inc.Quarterly Trade Report & Community Verified Swing Trade Signals - newser.com
Why Adicet Bio Inc. (1IJA) stock could rally strongly2025 Market Outlook & AI Driven Stock Movement Reports - newser.com
How strong is Adicet Bio Inc. stock revenue growth2025 Earnings Impact & Free Technical Pattern Based Buy Signals - newser.com
Orbimed advisors buys Adicet Bio (ACET) shares worth $5 million - Investing.com India
Orbimed advisors buys Adicet Bio (ACET) shares worth $5 million By Investing.com - Investing.com UK
What moving averages say about Adicet Bio Inc.2025 Price Targets & Entry Point Confirmation Alerts - newser.com
Multi factor analysis applied to Adicet Bio Inc.July 2025 Institutional & Real-Time Stock Movement Alerts - newser.com
Adicet Bio’s SWOT analysis: cell therapy stock faces pivotal moment By Investing.com - Investing.com Australia
What RSI levels show for Adicet Bio Inc. (1IJA) stockJuly 2025 Reactions & High Conviction Investment Ideas - newser.com
Guggenheim Maintains Adicet Bio (ACET) Buy Recommendation - Nasdaq
Adicet Bio’s SWOT analysis: cell therapy stock faces pivotal moment - Investing.com India
Adicet Bio (NASDAQ:ACET) Earns Sell (E+) Rating from Weiss Ratings - MarketBeat
Adicet Bio Inc Stock Analysis and ForecastBreakout Stock Watch & Grow Steadily With Our Wealth Roadmap - earlytimes.in
Adicet Bio stock holds steady as Citizens reiterates Market Perform - Investing.com
Adicet Bio reports positive results from ADI-001 autoimmune trial By Investing.com - Investing.com Canada
Adicet Bio Receives Nasdaq Extension for Compliance - TipRanks
Guggenheim raises Adicet Bio stock price target on positive lupus data - Investing.com
Adicet Bio Announces $80 Million Offering - citybiz
Adicet Bio's Lupus Trial Delivers 100% Response, Setting Stage For Phase 2 - Benzinga
Are Medical Stocks Lagging Exact Sciences (EXAS) This Year? - sharewise.com
Adicet Bio prices $80 million stock offering at $1 per share - Investing.com Nigeria
Adicet Bio reports positive results from ADI-001 autoimmune trial - Investing.com
Adicet Bio Announces Major Stock Offering Agreement - TipRanks
Adicet Bio Reports Promising Phase 1 Study Results - TipRanks
Adicet Bio Announces Positive Preliminary Data from ADI-001 Phase 1 Study in Patients with Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE) - NewsBreak: Local News & Alerts
Adicet Bio, Inc. Announces $80 Million Registered Direct Offering - The Joplin Globe
70.0M shares: Adicet Bio Prices $80M Registered Direct Offering - Stock Titan
Adicet Bio, Inc. (NASDAQ:ACET) Receives $5.33 Consensus Target Price from Brokerages - Defense World
What analysts say about Adicet Bio Inc stockMid Cap Growth Trends & Free Explosive Portfolio Gains - earlytimes.in
Evaluating Adicet Bio Inc. with trendline analysisWeekly Trade Recap & Daily Profit Maximizing Tips - newser.com
Why Adicet Bio Inc. stock remains on buy listsMarket Activity Report & Reliable Volume Spike Alerts - newser.com
Can Adicet Bio Inc. (1IJA) stock reach $200 price targetQuarterly Portfolio Report & Expert Approved Momentum Ideas - newser.com
What to expect from Adicet Bio Inc. in the next 30 days2025 Historical Comparison & AI Forecasted Entry/Exit Points - newser.com
Adicet Bio, Inc. (NASDAQ:ACET) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Is Adicet Bio Inc a good long term investmentPrice Action Trading & High Profit Trading Alerts - earlytimes.in
What momentum shifts mean for Adicet Bio Inc.July 2025 Movers & Community Verified Swing Trade Signals - newser.com
Adicet Bio Inc (ACET) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.24%
자본화:
|
볼륨(24시간):